Search

Your search keyword '"Ballerini, F"' showing total 6 results
Start Over Author "Ballerini, F" Publisher wiley
6 results on '"Ballerini, F"'

1. EARLY METABOLIC RESPONSE IN FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL)

Author

Luminari, S., primary, Guerra, L., additional, Durmo, R., additional, Chauvie, S., additional, Peano, S., additional, Franceschetto, A., additional, Fallanca, F., additional, Tarantino, V., additional, Pinto, A., additional, Ghiggi, C., additional, Pulsoni, A., additional, Merli, M., additional, Farina, L., additional, Tani, M., additional, Botto, B., additional, Musuraca, G., additional, Falini, B., additional, Ballerini, F., additional, Stefani, P. M., additional, Bolis, S., additional, Pietrantuono, G., additional, Manni, M., additional, Marcheselli, L., additional, Federico, M., additional, and Versari, A., additional

Published
2021
Full Text
View/download PDF

2. ROMIDEPSIN‐CHOEP PLUS UP‐FRONT STEM‐CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): FIRST ANALYSIS OF THE PHASE II FIL‐PTCL13 STUDY

Author

Chiappella, A., primary, Carniti, C., additional, Re, A., additional, Castellino, C., additional, Evangelista, A., additional, Ciancia, R., additional, Orsucci, L., additional, Pinto, A., additional, Usai, S. V., additional, Arcari, A., additional, Ilariucci, F., additional, Rossi, F. G., additional, Benedetti, F., additional, Flenghi, L., additional, Ghiggi, C., additional, Molinari, A. L., additional, Stefoni, V., additional, Volpetti, S., additional, Zilioli, V. R., additional, Ballerini, F., additional, Bruna, R., additional, Cavallo, F., additional, Musuraca, G., additional, Patti, C., additional, Re, F., additional, Tani, M., additional, Varettoni, M., additional, Zanni, M., additional, Dodero, A., additional, Pileri, S. A., additional, Ciccone, G., additional, and Corradini, P., additional

Published
2021
Full Text
View/download PDF

3. LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B-CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL)

Author

Gini, G., primary, Tani, M., additional, Bassan, R., additional, Tucci, A., additional, Ballerini, F., additional, Sampaolo, M., additional, Merli, F., additional, Re, F., additional, Annibali, O., additional, Liberati, A., additional, Visco, C., additional, Arcari, A., additional, Storti, S., additional, Fabbri, A., additional, Musuraca, G., additional, Zilioli, V., additional, Cox, M., additional, and Luminari, S., additional

Published
2019
Full Text
View/download PDF

4. First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease

Author

Clavio, M., primary, Miglino, M., additional, Spriano, M., additional, Pietrasanta, D., additional, Vallebella, E., additional, Celesti, L., additional, Canepa, L., additional, Pierri, I., additional, Cavaliere, M., additional, Ballerini, F., additional, Beltrami, G., additional, Rossi, E., additional, Vimercati, R., additional, Bruni, R., additional, Congiu, M., additional, Nati, S., additional, Damasio, E., additional, Santini, G., additional, and Gobbi, M., additional

Published
2009
Full Text
View/download PDF

5. Salvage Therapy With Thalidomide In Patients With Advanced Relapsed/Refractory Multiple Myeloma

Author

Tosi, P, primary, Zamagni, E, additional, Cellini, C, additional, Ronconi, S, additional, Patriarca, F, additional, Ballerini, F, additional, Musto, P, additional, Di Raimondo, F, additional, Ledda, A, additional, Lauria, F, additional, Masini, L, additional, Gobbi, M, additional, Vacca, A, additional, Ria, R, additional, Cangini, D, additional, Tura, S, additional, Baccarani, M, additional, and Cavo, M., additional

Published
2002
Full Text
View/download PDF

6. Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.

Author

Cagnetta A, Lovera D, Grasso R, Colombo N, Canepa L, Ballerini F, Calvio M, Miglino M, Gobbi M, Lemoli R, and Cea M

Subjects
Animals, DNA Damage genetics, Humans, Models, Genetic, Mutation genetics, DNA, Neoplasm genetics, Gene Expression Regulation, Neoplastic genetics, Genes, Neoplasm genetics, Genome, Human genetics, Genomic Instability genetics, Multiple Myeloma genetics
Abstract

Ongoing genomic instability represents a hallmark of multiple myeloma (MM) cells, which manifests largely as whole chromosome- or translocation-based aneuploidy. Importantly, although it supports tumorigenesis, progression and, response to treatment in MM patients, it remains one of the least understood components of malignant transformation in terms of molecular basis. Therefore these aspects make the comprehension of genomic instability a pioneering strategy for novel therapeutic and clinical speculations to use in the management of MM patients. Here we will review mechanisms mediating genomic instability in MM cells with an emphasis placed on pathogenic mutations affecting DNA recombination, replication and repair, telomere function and mitotic regulation of spindle attachment, centrosome function, and chromosomal segregation. We will discuss the mechanisms by which genetic aberrations give rise to multiple pathogenic events required for myelomagenesis and conclude with a discussion of the clinical applications of these findings in MM patients.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results